Astrazeneca Pharma India Ltd.

₹8,550

159 (1.9%)

ASTRAZEN Share Price

Pharmaceuticals & Biotechnology

As on January 30, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 21,350 Cr

P/E Ratio184.68

Dividend Yield0.19 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	8,412.7	Bullish
10-DMA	8,348.05	Bullish
20-DMA	8,382.3	Bullish
50-DMA	8,795.67	Bearish
100-DMA	8,983.99	Bearish
200-DMA	8,902.42	Bearish

Historical Performance

1 Year

17.7%

3 Years

154.7%

5 Years

135.8%

10 Years

591.8%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Compounded Sales Growth

10 Years:27.1

5 Years:15.6

3 Years:16.3

TTM:5.8

Compounded Profit Growth

10 Years:14

5 Years:9.9

3 Years:13.4

TTM:-6.4

Stock Price CAGR

10 Years:21.3

5 Years:18.7

3 Years:36.5

TTM:18.2

Return on Equity

10 Years:2.1

5 Years:37.3

3 Years:39.7

last year:46.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 184.68, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 36.5%, indicating sustained price appreciation.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹2946 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹17163 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1181739

No. of Shares: 138 (Approx)

Performance:18.2%

P/L: ₹181739

NIFTY Performance: 7.7%

1 day Top Gainers

Symbol	Change%
RAYMONDLSL	1047.9(14%)
IDEA	11.17(11%)
RHIM	445.1(8%)
SIGNATURE	901.2(8%)
TTML	45.66(7%)

1 Day Top Losers

Symbol	Change%
HINDZINC	628.5(-12%)
VEDL	681.55(-11%)
NATIONALUM	385.45(-10%)
HINDCOPPER	685.9(-10%)
GRAPHITE	617.3(-7%)
NTPCGREEN	86.17(-7%)
GMDCLTD	577.75(-7%)
MUTHOOTFIN	3829.6(-6%)